Serina Therapeutics SER
NYSE SER
$2.00 -0.01 (-0.48%)
As of: Oct 1, 2026 · 3:14 PM EDT

Serina Therapeutics (SER) Short term Debt (2020 - 2025)

Updated

Serina Therapeutics (SER) posted Short term Debt of $2.89 million for Q3 2025, down 72.4% from $10.46 million a year earlier.

Analysis

Serina Therapeutics (SER) Short term Debt (2020 - 2025) Analysis & Trends

At the end of FY2022, Serina Therapeutics' Short term Debt came in at $7.65 million, up 7.1% from FY2021.

  • In prior years, Serina Therapeutics' Short term Debt was $7.14 million in FY2021 and $436,000 in FY2020.
  • The Q3 2025 figure stands as the lowest quarterly Short term Debt since Q3 2023.
  • On a year-over-year basis, Short term Debt increased in 1 of the last four quarters, with growth averaging 101.8%.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Serina Therapeutics 32.93 Mn -7.81 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 2.89 Mn
Sep 30, 2024 10.46 Mn
Jun 30, 2024 10.45 Mn
Mar 31, 2024 9.75 Mn
Sep 30, 2023 1.53 Mn
Jun 30, 2023 22.94 Mn
Mar 31, 2023 20.04 Mn
Dec 31, 2022 7.65 Mn
Sep 30, 2022 7.30 Mn
Dec 31, 2021 7.14 Mn
Dec 31, 2020 436,000.00
Sep 30, 2020 435,000.00
API Access

Serina Therapeutics Short term Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=short-term-debt&ticker=SER&period=max&api_key=YOUR_API_KEY